Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"FAM166A, pseudogene 9" is a genomic region classified as a pseudogene, derived from the Family with sequence similarity 166, member A (FAM166A) protein-coding gene[12][9]. Pseudogenes are DNA sequences that closely resemble functional genes but have lost their protein-coding ability due to mutations, lack of regulatory sequences, or incomplete processing[6][12]. While most pseudogenes are considered nonfunctional, some may produce noncoding RNA and participate in regulatory processes or gene conversion events linked to disease, although such roles are rare and not documented for this particular pseudogene[6][7]. No evidence supports its use as a therapeutic target, biomarker, or its involvement in drug action.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 166, member A pseudogene 9 (FAM166A, pseudogene 9).